Assessment of AI-based computational H&E staining versus chemical H&E staining for primary diagnosis in lymphomas: a brief interim report.
Rima KokaLaura M WakeNam K KuKathryn RiceAutumn LaRocqueElba G VidalSerge AlexanianRaymond KozikowskiYair RivensonMichael Edward KallenPublished in: Journal of clinical pathology (2024)
Microscopic review of tissue sections is of foundational importance in pathology, yet the traditional chemistry-based histology laboratory methods are labour intensive, tissue destructive, poorly scalable to the evolving needs of precision medicine and cause delays in patient diagnosis and treatment. Recent AI-based techniques offer promise in upending histology workflow; one such method developed by PictorLabs can generate near-instantaneous diagnostic images via a machine learning algorithm. Here, we demonstrate the utility of virtual staining in a blinded, wash-out controlled study of 16 cases of lymph node excisional biopsies, including a spectrum of diagnoses from reactive to lymphoma and compare the diagnostic performance of virtual and chemical H&Es across a range of stain quality, image quality, morphometric assessment and diagnostic interpretation parameters as well as proposed follow-up immunostains. Our results show non-inferior performance of virtual H&E stains across all parameters, including an improved stain quality pass rate (92% vs 79% for virtual vs chemical stains, respectively) and an equivalent rate of binary diagnostic concordance (90% vs 92%). More detailed adjudicated reviews of differential diagnoses and proposed IHC panels showed no major discordances. Virtual H&Es appear fit for purpose and non-inferior to chemical H&Es in diagnostic assessment of clinical lymph node samples, in a limited pilot study.
Keyphrases
- lymph node
- machine learning
- artificial intelligence
- image quality
- deep learning
- big data
- computed tomography
- clinical trial
- systematic review
- squamous cell carcinoma
- magnetic resonance
- quality improvement
- diffuse large b cell lymphoma
- magnetic resonance imaging
- radiation therapy
- optical coherence tomography
- ultrasound guided
- electronic health record
- placebo controlled